SecBot SecBot
Insider Cluster (2 insiders) ·Filed Jul 1, 2026

IBRX

ImmunityBio, Inc.
NEUTRAL
Impact 2/10
Horizondays Processed4mo ago
Insider cluster: 2 insiders, $1.1M total
Actionable Insight • Neutral

This cluster is entirely director-level selling with no C-suite participation, totaling just 0.011% of market cap, well below any materiality threshold. The sales are likely liquidity-driven following derivative exercises. No actionable signal for traders; ignore this cluster.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$9.44
T+0 close · Jul 1, 2026 · via day close
Latest settled
−9.75%
T+60 · $8.52
Vs SPY
−12.54%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 2 $9.44entry
  2. T+1 · 4mo ago −5.61%α −6.49% · $8.91
  3. T+5 · 4mo ago −12.92%α −14.29% · $8.22
  4. T+20 · 4mo ago −24.05%α −24.35% · $7.17
  5. T+60 · 7w ago −9.75%α −12.54% · $8.52
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two directors at ImmunityBio sold a combined ~$1.06M in open-market sales over a 7-day window, with the largest sale ($862K) occurring on June 29 at ~$9.01. The cluster is 100% selling by non-C-suite directors, with total value representing ~0.01% of the $9.6B market cap, well below the 0.1% materiality threshold. The sales are trivial relative to company size and carry no informational signal per the academic literature on director-level sales.

Key Financial Metrics

Direction
selling
Total Value
$1.1M
Insiders
2

Key Facts

  • Two directors sold a combined ~$1.06M in open-market sales over a 7-day window ending June 29, 2026
  • Total sales represent ~0.011% of IBRX's $9.6B market cap, well below the 0.1% materiality threshold
  • No C-suite executives (CEO, CFO, COO) participated in any trades, only directors
  • Director Selecky Christobel's sales ($871K) were preceded by derivative exercises at $2.98 strike, suggesting tax/vesting-related liquidity rather than a bearish view
  • Director Simon Barry J. sold $197K at $7.88, a trivial amount for a $9.6B company

Financial Impact

Total insider sales of ~$1.06M represent ~0.011% of IBRX's $9.6B market cap, trivial and routine

insider_ownershipfloat

Risk Factors

  • No C-suite participation in this cluster, director-level sales carry minimal informational content

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
90% bullish (10 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-IBRX-1782976386047

Track record

11 reports on IBRX

Performance horizon

1 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +19.12% at T+60 after the Apr 9, 2026 report. 2 of 5 went positive at some point.

Filters
  1. Nov 9, 20267d ago 8-K Neutral 5/10 Entry $7.11 Now $5.98 −15.89% settles Feb 5
  2. Nov 9, 20267d ago 8-K Bullish 6/10 Entry $7.11 Now $5.98 −15.89% settles Feb 5
  3. Nov 4, 202612d ago Institutional Cluster Neutral 3/10 Entry $8.93 Now $5.98 −33.03% settles Feb 2
  4. Oct 14, 20264w ago 8-K Bullish 7/10 Entry $10.00 Now $5.98 −40.20% settles Jan 12
  5. Aug 4, 202614w ago 8-K Neutral 5/10 Entry $6.95 to $8.63 Now $5.98 −13.96% ▲ +24.17% +24.39% vs SPY
  6. Jul 6, 202619w ago Insider Cluster Neutral 2/10 Entry $8.76 to $9.44 Now $5.98 −31.74% ▲ +7.76% +5.77% vs SPY
  7. Jul 1, 202619w ago Insider Cluster Neutral 2/10 Viewing Entry $9.44 to $8.52 Now $5.98 −36.65% ▼ −9.75% −12.54% vs SPY
  8. May 18, 202626w ago 8-K Bullish 5/10 Entry $7.76 to $7.65 Now $5.98 −22.94% ▼ −1.42% −7.71% vs SPY
  9. Apr 9, 202631w ago 8-K Bullish 8/10 Entry $7.48 to $8.91 Now $5.98 −20.05% ▲ +19.12% +8.34% vs SPY
  10. Apr 6, 202632w ago 8-K Neutral 4/10 Entry $7.08 to $9.20 Now $5.98 −15.54% ▲ +29.94% +16.47% vs SPY
Showing 10 of 11

US Market Status

Market Closed · Opens Wed (9h 47m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 2, 2026